Merck reaches deal to expand HIV drug access via ADAP programs

Go back to Merck reaches deal to expand HIV drug access via ADAP programs
Merck & Co. (NYSE: MRK) Delayed: 146.87 -0.28 (0.19%)
Previous Close $147.15    52 Week High $65.46 
Open $147.08    52 Week Low $47.97 
Day High $147.84    P/E 99.91 
Day Low $145.74    EPS $1.47 
Volume 29,115,136